DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tobradex (Tobramycin / Dexamethasone Ophthalmic) - Current Clinical Trials

 
 



Tobradex Related Clinical Trials

TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension [Completed]

A Bioequivalence Study of Tobradex AF [Completed]

Tobramycin Tear Concentrations [Completed]

Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex [Completed]

Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle [Withdrawn]

Zylet vs TobraDex in Blepharokeratoconjunctivitis [Completed]

Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis [Not yet recruiting]

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis [Completed]

A Clinical Study of Tobradex AF [Completed]

Ketorolac Plus Tobramycin/Dexamethasone Versus Tobramycin/Dexamethasone After Uneventful Phacoemulsification Surgery [Completed]

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis [Completed]

Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery [Completed]

Chalazion Treatment Trial [Not yet recruiting]

Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis [Terminated]

Intraocular Pressure With Loteprednol and Dexamethasone [Completed]

TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy [Completed]

VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia [Not yet recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017